Antibody News and Research

RSS
An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Further Reading

Soluble ACE2 microbody blocks SARS-CoV-2 entry into lung cells

Soluble ACE2 microbody blocks SARS-CoV-2 entry into lung cells

COVAM assay may help select convalescent plasma units for treatment of  acute COVID-19

COVAM assay may help select convalescent plasma units for treatment of acute COVID-19

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

New method isolates antibody-like proteins that capture and neutralize SARS-CoV-2

New method isolates antibody-like proteins that capture and neutralize SARS-CoV-2

UM receives $33.4 million for development and clinical trials of opioid vaccines

UM receives $33.4 million for development and clinical trials of opioid vaccines

Combination of two mosquito-borne viruses may be a trigger for stroke

Combination of two mosquito-borne viruses may be a trigger for stroke

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

T cells on the front line of COVID-19 response

T cells on the front line of COVID-19 response

Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus

Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus

Study: T cells play a vital role in controlling SARS-CoV-2 during acute phase of infection

Study: T cells play a vital role in controlling SARS-CoV-2 during acute phase of infection

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Seropositive partners increase risk of COVID-19 but not obstetric complications in pregnant women

Seropositive partners increase risk of COVID-19 but not obstetric complications in pregnant women

Blood viscometers could help guide the treatment of Covid-19 patients

Blood viscometers could help guide the treatment of Covid-19 patients

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

ERS Genomics and Applied StemCell sign agreement on commercialization of CRISPR gene editing tools

ERS Genomics and Applied StemCell sign agreement on commercialization of CRISPR gene editing tools

Self-assembling nanoparticles as a way towards next-generation COVID-19 vaccines

Self-assembling nanoparticles as a way towards next-generation COVID-19 vaccines

Candidate monoclonal antibody shows hope as COVID-19 treatment

Candidate monoclonal antibody shows hope as COVID-19 treatment

Critical insights into COVID-19 exposure for healthcare workers

Critical insights into COVID-19 exposure for healthcare workers

Study highlights role of specific protein in the mass production of antibodies

Study highlights role of specific protein in the mass production of antibodies